Clinical characteristics, therapy and outcome of bloodstream infections caused by vancomycin-resistant enterococci: a multicentre clinical experience
Journal of Antimicrobial Chemotherapy · 02.05.2025 · 80 (5) · 1241-1247
DOI: 10.1093/jac/dkaf055 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 25.02.2025. Verfasst von Francesca Serapide und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences, Infectious and Tropical Disease Unit, 'Magna Graecia' University of Catanzaro, Catanzaro, Italy. Hauptthemen laut MEDLINE: Gram-Positive Bacterial Infections, Anti-Bacterial Agents, Vancomycin-Resistant Enterococci, Bacteremia. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
Objectives
Bloodstream infections (BSIs) due to vancomycin-resistant Enterococcus spp. (VRE) are considered a predictor of mortality among frail patients. The aim of this study was to evaluate the risk factors associated with 30 day mortality and relapse of infection in enterococcal BSI caused by VRE and to evaluate the impact of antibiotic regimens in targeted therapy.
Methods
We conducted a retrospective study of consecutive hospitalized patients in six teaching hospitals from August 2016 to August 2022 in Italy. All adult patients with a documented VRE BSI were included.
Results
We enrolled 517 consecutive hospitalized patients with VRE BSI; of these BSIs 496 (96.5%) were caused by Enterococcus faecium and 26 (5.1%) by Enterococcus faecalis. The most frequently used antibiotics as backbone were linezolid (48.1%) and daptomycin (43.7%). Overall, the 30 day mortality was 32.1%. Upon Cox regression analysis, the risk factor independently associated with 30 day mortality was Charlson comorbidity index >3 points (P < 0.001), whereas a Pitt score <4 points (P = 0.031), surgery for source control of infection (P = 0.016) and time to targeted therapy <24 h (P = 0.006) were associated with survival. After propensity score adjustment, a daptomycin-based regimen (P = 0.003) was associated with 30 day survival.
Conclusions
VRE BSI is an important cause of mortality in frail/critically ill patients. Our data highlighted the role of daptomycin as backbone agent for the treatment of enterococcal BSI caused by vancomycin-resistant strains.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical and Surgical Sciences, Infectious and Tropical Disease Unit, 'Magna Graecia' University of Catanzaro, Catanzaro, Italy.
- Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy.
- Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.
- Department of Medical Sciences, Infectious Diseases, University of Turin, Turin, Italy.
- Infectious Disease Unit, University Hospital of Modena, University of Modena and Reggio Emilia, Modena, Italy.
- Department of Medicine and Surgery, Infectious and Tropical Diseases Unit, University of Insubria-ASST-Sette Laghi, Varese, Italy.
ORCID-Profile: Giuseppe Biondi-Zoccai, Francesco Giuseppe De Rosa, Marco Falcone, Paolo Antonio Grossi
Zitieren
APA
Serapide, F., Serraino, R., Spadafora, L., Bernardi, M., Brucci, G., Cattardico, G., Corcione, S., De Benedetto, I., Del Monte, M., Limongelli, A., Giacobbe, D. R., Graziano, E., Meschiari, M., Pinna, S. M., Peghin, M., Tiseo, G., Vena, A., Romeo, F., Sarto, G., …, & Russo, A. (2025). Clinical characteristics, therapy and outcome of bloodstream infections caused by vancomycin-resistant enterococci: a multicentre clinical experience. Journal of Antimicrobial Chemotherapy, 80(5), 1241-1247. https://doi.org/10.1093/jac/dkaf055
Vancouver
Serapide F, Serraino R, Spadafora L, Bernardi M, Brucci G, Cattardico G, et al. Clinical characteristics, therapy and outcome of bloodstream infections caused by vancomycin-resistant enterococci: a multicentre clinical experience. Journal of Antimicrobial Chemotherapy. 2025;80(5):1241-1247. doi:10.1093/jac/dkaf055
BibTeX
@article{Serapide2025,
author = {Serapide, Francesca and Serraino, Riccardo and Spadafora, Luigi and Bernardi, Marco and Brucci, Giorgia and Cattardico, Greta and Corcione, Silvia and De Benedetto, Ilaria and Del Monte, Martina and Limongelli, Alessandro and Giacobbe, Daniele Roberto and Graziano, Elena and Meschiari, Marianna and Pinna, Simone Mornese and Peghin, Maddalena and Tiseo, Giusy and Vena, Antonio and Romeo, Francesco and Sarto, Gianmarco and Bassetti, Matteo and Biondi-Zoccai, Giuseppe and De Rosa, Francesco Giuseppe and Falcone, Marco and Grossi, Paolo Antonio and Mussini, Cristina and Russo, Alessandro},
title = {Clinical characteristics, therapy and outcome of bloodstream infections caused by vancomycin-resistant enterococci: a multicentre clinical experience},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2025},
volume = {80},
number = {5},
pages = {1241--1247},
doi = {10.1093/jac/dkaf055}
}
EUVIMED